Ranibizumab Intraocular and Tetracycline (class) Oral, Parenteral
Determining the interaction of Ranibizumab Intraocular and Tetracycline (class) Oral, Parenteral and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
Generic Name: tetracycline
Brand name: Ala-Tet, Brodspec, Panmycin, Sumycin, Tetracap, Tetracon, Robitet 500, Emtet-500
Synonyms: Tetracycline, Tetracycline (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ranibizumab Intraocular-Tetracycline (Systemic)
- Ranibizumab Intraocular-Tetracycline Hydrochloride
- Ranibizumab Intraocular-Tetracycline Mucous membrane, oral
- Ranibizumab Intraocular-Tetracycline Topical application
- Ranibizumab Intraocular-Tetrahydrozoline (Nasal)
- Ranibizumab Intraocular-Tetrahydrozoline and zinc ophthalmic
- Tetracycline (class) Oral, Parenteral-Ranibizumab ophthalmic
- Tetracycline (class) Oral, Parenteral-Ranitidine
- Tetracycline (class) Oral, Parenteral-Ranitidine Capsule
- Tetracycline (class) Oral, Parenteral-Ranitidine Hydrochloride
- Tetracycline (class) Oral, Parenteral-Ranitidine Injection
- Tetracycline (class) Oral, Parenteral-Ranitidine Suspension